Jeevaraj R

Mr. Jeevaraj R

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
VKVinothkumar Kolluru
Vinothkumar Kolluru
SHShreyas Rajendra Hole
Shreyas Rajendra Hole
ASAjeeb Sagar
Ajeeb Sagar
ACAdvaitha Naidu Chintakunta
Advaitha Naidu Chintakunta
JRJeevaraj R
Jeevaraj R
Shreekant SalotagiShreekant Salotagi
Shreekant Salotagi
Background: Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is an escalating global health challenge, affecting over 82 million individuals each year. The increasing resistance to commonly used antibiotics such as azithromycin, ciprofloxacin, and cefixime hinders timely and effective treatment, primarily due to the delayed detection of resistant strains. Methods: To overcome these limitations, a hybrid machine learning (ML) and deep learning (DL) framework was developed using a dataset comprising 3786 N. gonorrhoeae isolates. The dataset included clinical metadata and phenotypic resistance profiles. The preprocessing steps involved handling 23% data sparsity, imputing 31 skewed columns, and applying resampling and harmonisation techniques sensitive to data skewness. A predictive pipeline was constructed using both clinical variables and genomic unitigs, and a suite of 33 classifiers was evaluated. Results: The CatBoost model emerged as the top-performing ML algorithm, particularly due to its proficiency in handling categorical data, while a three-layered neural network served as the DL baseline. The ML models outperformed genome-wide association study (GWAS) benchmarks, achieving AUC scores of 0.97 (ciprofloxacin), 0.95 (cefixime), and 0.94 (azithromycin), representing a 4–7% improvement. SHAP analysis identified biologically relevant resistance markers, such as penA mosaic alleles and mtrR promoter mutations, validating the interpretability of the model. Conclusions: The study highlights the potential of ML-driven approaches to enhance the real-time prediction of antimicrobial resistance in N. gonorrhoeae. These methods can significantly contribute to antibiotic stewardship programs, although further validation is required in low-resource settings to confirm their generalisability and robustness across diverse populations.

29 May 2026 in Journal of Internet Services and Information Security
Verified
Journal Article
Closed access
JRJeevaraj R
Jeevaraj R
ASAjay Kumar Singh
Ajay Kumar Singh
As counterfeit drugs continue to become more prevalent in the pharmaceutical supply chain, it poses significant threats to patient safety, public health, and economic stability. The traditional pharmaceutical supply chain systems are primarily based on centralised databases and manual checks, which limits transparency, traceability and data integrity. According to various global health organizations, counterfeit drugs make up more than 10% of the pharmaceutical products in developing nations, and great need of a secure and transparent monitoring system. The goal of this study is to create a framework for a blockchain and Internet of Things (IoT) enabled pharmaceutical supply chain that can enhance the tracing and security of pharmaceuticals. It combines the technology of distributed ledger with IoT sensing devices to create a secure transaction validation, real-time monitoring and tamper-resistant tracking system in the supply chain. A mathematical model that is based on this probabilistic aspect of the sensing reliability and verification frequency is developed for the evaluation of the probability of detecting a counterfeit drug. Moreover, an adversarial behavior and economic incentives analysis using a game-theoretic security model is provided to help understand the CTD problem. The real-time logistics monitoring and secure cloud verification are implemented using edge devices based on AM62x. Experimental results indicate that the proposed framework can achieve a higher probability of counterfeit detection (up to 0.89-0.98) compared with the conventional systems (0.48), and can reduce the transaction confirmation latency from 250 ms to 80 ms. The results indicate that there is greater transparency, trust and resiliency in the pharmaceutical supply chains.